Palliative Treatment of Malignant Ascites: Profile of Catumaxomab

Biologics: Targets and Therapy - New Zealand
doi 10.2147/btt.s6697
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Pathophysiology of Elevated Ascites Fluid Cholesterol in Malignant Ascites

Journal of Hepatology
Hepatology
1992English

Palliative Treatment of Malignant Esophageal-Cardiac Stricture in the Ederly

BMC Geriatrics
GerontologyGeriatrics
2010English

Vesicular Stomatitis Virus Is a Potent Agent for the Treatment of Malignant Ascites

Oncology Reports
MedicineCancer ResearchOncology
2015English

Catumaxomab

mAbs
AllergyImmunology
2010English

Malignant Ascites: A Review of Pathogenesis and Management

Open Access Journal of Surgery
2017English

Self-Expanding Duodenal Stents, Palliative Treatment of Gastric Outlet Obstruction in Malignant Disease

Gastroenterologie a Hepatologie
HepatologyGastroenterology
2018English

Diagnosis and Treatment of Ascites

Journal of Hepatology
Hepatology
2017English

Feasibility of Externalized Peritoneovenous Shunt (EPVS) for Malignant Ascites

World Journal of Surgical Oncology
SurgeryOncology
2011English

Efficacy of Cell-Free and Concentrated Ascites Reinfusion Therapy for Palliative Care in a Patient With Malignant Pleural Mesothelioma: A Case Report

Journal of Nippon Medical School
Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy